Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mohammed Orloff

Concepts (236)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genetic Predisposition to Disease
11
2024
510
1.120
 Why?
Germ-Line Mutation
9
2013
61
1.100
 Why?
Hamartoma Syndrome, Multiple
8
2012
15
1.100
 Why?
PTEN Phosphohydrolase
13
2015
55
1.070
 Why?
Barrett Esophagus
2
2019
29
1.040
 Why?
Esophageal Neoplasms
2
2019
99
0.960
 Why?
Adenocarcinoma
3
2019
401
0.850
 Why?
Haplotypes
3
2020
83
0.800
 Why?
Homozygote
3
2019
56
0.680
 Why?
Polymorphism, Single Nucleotide
9
2021
485
0.680
 Why?
Carcinoma, Non-Small-Cell Lung
1
2020
152
0.650
 Why?
Proto-Oncogene Proteins c-akt
4
2012
157
0.610
 Why?
Databases, Factual
1
2020
664
0.580
 Why?
Alleles
6
2021
251
0.470
 Why?
Lung Neoplasms
3
2020
605
0.460
 Why?
Phosphatidylinositol 3-Kinases
2
2012
141
0.430
 Why?
Genotype
6
2021
538
0.420
 Why?
Scavenger Receptors, Class A
1
2011
39
0.380
 Why?
Extracellular Matrix Proteins
1
2011
69
0.380
 Why?
Genetic Variation
3
2021
214
0.300
 Why?
Transcription Factors
1
2011
563
0.300
 Why?
Breast Neoplasms
7
2017
1169
0.300
 Why?
Thyroid Neoplasms
4
2012
109
0.290
 Why?
Humans
37
2024
49827
0.290
 Why?
Heart Defects, Congenital
2
2024
592
0.280
 Why?
Case-Control Studies
4
2024
1128
0.270
 Why?
Genes, Wilms Tumor
1
2005
1
0.250
 Why?
Population
1
2005
8
0.250
 Why?
Gene Frequency
3
2020
94
0.250
 Why?
Glomerulosclerosis, Focal Segmental
1
2005
13
0.250
 Why?
Genome
2
2019
67
0.240
 Why?
Lamin Type A
1
2024
7
0.240
 Why?
Capacity Building
1
2024
17
0.230
 Why?
DNA Methylation
3
2024
548
0.230
 Why?
Adult
16
2024
13160
0.220
 Why?
Middle Aged
16
2021
11997
0.220
 Why?
Linkage Disequilibrium
2
2020
37
0.220
 Why?
Female
21
2024
26329
0.220
 Why?
Smoke-Free Policy
1
2022
8
0.210
 Why?
Tobacco Smoke Pollution
1
2022
48
0.200
 Why?
Inheritance Patterns
1
2021
22
0.190
 Why?
Phenotype
7
2021
727
0.190
 Why?
Models, Genetic
5
2013
174
0.190
 Why?
Risk Factors
5
2019
3619
0.190
 Why?
Male
15
2024
25093
0.180
 Why?
Succinate Dehydrogenase
2
2011
23
0.180
 Why?
Aged
11
2020
9272
0.180
 Why?
Stilbenes
2
2010
62
0.180
 Why?
Fires
1
2020
13
0.180
 Why?
Agriculture
1
2020
19
0.170
 Why?
Social Media
1
2021
97
0.170
 Why?
Tobacco Products
1
2021
110
0.170
 Why?
Aged, 80 and over
5
2020
3125
0.170
 Why?
Cluster Analysis
4
2013
235
0.170
 Why?
Exome
1
2019
46
0.170
 Why?
Genomics
1
2020
282
0.160
 Why?
Cell Proliferation
3
2010
1007
0.150
 Why?
Pulmonary Disease, Chronic Obstructive
1
2020
130
0.150
 Why?
Prostatic Neoplasms
2
2012
396
0.150
 Why?
Gene Expression Regulation, Neoplastic
3
2010
829
0.150
 Why?
Prognosis
2
2020
1952
0.140
 Why?
Endometrial Neoplasms
2
2015
137
0.140
 Why?
Leprosy
1
2016
6
0.140
 Why?
Asthma
1
2020
283
0.130
 Why?
Hypertension
1
2021
532
0.130
 Why?
Emergency Service, Hospital
1
2020
488
0.130
 Why?
Microsatellite Repeats
2
2012
37
0.130
 Why?
Regression Analysis
2
2017
395
0.130
 Why?
Aromatase
1
2015
8
0.130
 Why?
Tuberculosis
1
2016
141
0.120
 Why?
Arkansas
4
2024
1967
0.120
 Why?
Genetic Linkage
2
2011
26
0.120
 Why?
Young Adult
7
2021
3936
0.120
 Why?
Adolescent
8
2021
6340
0.110
 Why?
Sirolimus
2
2010
62
0.110
 Why?
Genome-Wide Association Study
2
2012
166
0.110
 Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
1
0.110
 Why?
Smad4 Protein
1
2013
6
0.110
 Why?
Genetic Testing
2
2010
116
0.110
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
18
0.110
 Why?
Cohort Studies
3
2012
1422
0.110
 Why?
Colonic Polyps
1
2013
36
0.110
 Why?
Receptors, Cell Surface
1
2013
121
0.100
 Why?
Mitochondrial Diseases
1
2012
42
0.100
 Why?
Codon, Nonsense
1
2012
26
0.100
 Why?
Flavin-Adenine Dinucleotide
1
2011
5
0.100
 Why?
NAD
1
2011
43
0.100
 Why?
Antigens, CD
1
2013
215
0.100
 Why?
Genes, p53
1
2011
51
0.100
 Why?
DNA, Neoplasm
1
2012
147
0.100
 Why?
Siblings
1
2011
33
0.100
 Why?
Mutation, Missense
1
2012
103
0.100
 Why?
Taxoids
1
2011
37
0.100
 Why?
Gene Expression Profiling
3
2012
1031
0.100
 Why?
Adenoma
1
2012
110
0.100
 Why?
Risk
1
2012
320
0.090
 Why?
Colorectal Neoplasms
2
2012
234
0.090
 Why?
Intestinal Polyps
1
2010
7
0.090
 Why?
Software
1
2013
273
0.090
 Why?
Tumor Microenvironment
1
2012
210
0.090
 Why?
Cephalometry
1
2010
17
0.090
 Why?
Receptors, Androgen
1
2010
46
0.090
 Why?
Gene Dosage
1
2009
78
0.090
 Why?
Head
1
2010
73
0.090
 Why?
Carcinoma, Transitional Cell
1
2010
53
0.090
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
142
0.080
 Why?
Patient Selection
1
2010
251
0.080
 Why?
Cell Communication
1
2009
69
0.080
 Why?
Drug Resistance, Neoplasm
1
2011
308
0.080
 Why?
Age Factors
1
2012
1090
0.080
 Why?
Immunohistochemistry
1
2011
971
0.080
 Why?
Urinary Bladder Neoplasms
1
2010
157
0.080
 Why?
Smoking
1
2012
510
0.080
 Why?
Prevalence
2
2021
943
0.070
 Why?
Prospective Studies
4
2017
2344
0.070
 Why?
Chromosome Mapping
2
2021
160
0.070
 Why?
Rural Population
2
2022
535
0.070
 Why?
Mass Screening
1
2010
351
0.070
 Why?
Cell Line, Tumor
4
2011
1402
0.070
 Why?
Physical Chromosome Mapping
1
2005
8
0.070
 Why?
Multiple Myeloma
1
2020
2910
0.070
 Why?
Antineoplastic Agents
2
2011
1172
0.070
 Why?
Frasier Syndrome
1
2005
1
0.060
 Why?
Denys-Drash Syndrome
1
2005
3
0.060
 Why?
Exons
1
2005
95
0.060
 Why?
Child
5
2020
6824
0.060
 Why?
CpG Islands
1
2024
107
0.060
 Why?
Models, Theoretical
1
2005
174
0.060
 Why?
Gene Expression Regulation
1
2008
979
0.060
 Why?
Mutation
2
2010
1293
0.060
 Why?
Biopsy
1
2005
582
0.050
 Why?
Polyproteins
1
2022
2
0.050
 Why?
Child, Preschool
3
2020
3853
0.050
 Why?
Risk Assessment
2
2021
1262
0.050
 Why?
RNA, Viral
1
2022
125
0.050
 Why?
Phosphoproteins
1
2022
113
0.050
 Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
5
0.050
 Why?
United States Food and Drug Administration
1
2021
92
0.050
 Why?
Membrane Glycoproteins
1
2022
240
0.050
 Why?
Azacitidine
1
2020
34
0.050
 Why?
Nutrition Surveys
1
2021
104
0.050
 Why?
Loss of Heterozygosity
2
2012
77
0.050
 Why?
United States
2
2021
4838
0.050
 Why?
Stromal Cells
2
2012
72
0.050
 Why?
TOR Serine-Threonine Kinases
2
2010
77
0.040
 Why?
Nicotine
1
2021
186
0.040
 Why?
Self Report
1
2021
192
0.040
 Why?
Pedigree
2
2010
122
0.040
 Why?
Seasons
1
2020
81
0.040
 Why?
Air Pollution
1
2020
43
0.040
 Why?
Neoplasms
1
2009
1233
0.040
 Why?
Signal Transduction
3
2010
1617
0.040
 Why?
Odds Ratio
1
2021
548
0.040
 Why?
Phosphorylation
2
2010
536
0.040
 Why?
Sensitivity and Specificity
2
2012
854
0.040
 Why?
Gene Expression
2
2012
608
0.040
 Why?
Predictive Value of Tests
2
2012
904
0.040
 Why?
Dexamethasone
1
2020
429
0.040
 Why?
Treatment Outcome
2
2020
5138
0.040
 Why?
Infant
2
2020
3551
0.040
 Why?
Angiopoietin-2
1
2017
14
0.040
 Why?
Angiopoietin-1
1
2017
16
0.040
 Why?
Receptor, TIE-2
1
2017
16
0.040
 Why?
Fibroblast Growth Factor 2
1
2017
34
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2017
43
0.040
 Why?
Dose-Response Relationship, Drug
2
2010
1374
0.040
 Why?
Matrix Metalloproteinase 9
1
2017
86
0.030
 Why?
Cross-Sectional Studies
1
2021
1541
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
201
0.030
 Why?
Neoadjuvant Therapy
1
2017
115
0.030
 Why?
Neovascularization, Pathologic
1
2017
161
0.030
 Why?
HapMap Project
1
2015
3
0.030
 Why?
Introns
1
2015
49
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
987
0.030
 Why?
Pilot Projects
1
2016
699
0.030
 Why?
Peutz-Jeghers Syndrome
1
2013
2
0.030
 Why?
Databases, Genetic
1
2013
88
0.030
 Why?
Genome, Human
1
2013
111
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.030
 Why?
Penetrance
1
2012
6
0.030
 Why?
Neoplasm Grading
1
2012
123
0.020
 Why?
Anthracyclines
1
2011
24
0.020
 Why?
Genetic Association Studies
1
2012
116
0.020
 Why?
Vincristine
1
2011
89
0.020
 Why?
Inhibitory Concentration 50
1
2010
76
0.020
 Why?
Paclitaxel
1
2011
84
0.020
 Why?
Formazans
1
2010
2
0.020
 Why?
Tetrazolium Salts
1
2010
13
0.020
 Why?
Immunoblotting
1
2010
118
0.020
 Why?
Androgen Antagonists
1
2010
11
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.020
 Why?
Drug Synergism
1
2010
150
0.020
 Why?
HEK293 Cells
1
2011
222
0.020
 Why?
Michigan
1
2010
18
0.020
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
16
0.020
 Why?
Mitogen-Activated Protein Kinases
1
2010
156
0.020
 Why?
Point Mutation
1
2010
65
0.020
 Why?
Neoplasm Transplantation
1
2010
85
0.020
 Why?
Epithelial Cells
1
2012
209
0.020
 Why?
Androgens
1
2010
69
0.020
 Why?
Kidney Neoplasms
1
2012
178
0.020
 Why?
Heredity
1
2009
2
0.020
 Why?
Transplantation, Heterologous
1
2010
74
0.020
 Why?
BRCA2 Protein
1
2009
15
0.020
 Why?
Endoscopy, Gastrointestinal
1
2010
73
0.020
 Why?
Adenosine Triphosphate
1
2011
234
0.020
 Why?
BRCA1 Protein
1
2009
30
0.020
 Why?
Comparative Genomic Hybridization
1
2009
47
0.020
 Why?
Polymerase Chain Reaction
1
2011
455
0.020
 Why?
Mice, Nude
1
2010
252
0.020
 Why?
Proteins
1
2012
341
0.020
 Why?
Chi-Square Distribution
1
2010
282
0.020
 Why?
Cell Cycle
1
2010
232
0.020
 Why?
Algorithms
1
2013
616
0.020
 Why?
Gene Deletion
1
2010
266
0.020
 Why?
Protein Binding
1
2011
660
0.020
 Why?
Diagnosis, Differential
1
2012
1036
0.020
 Why?
Cell Survival
1
2010
598
0.020
 Why?
Incidence
1
2012
1003
0.020
 Why?
Neoplasm Invasiveness
1
2009
268
0.020
 Why?
Cell Transformation, Neoplastic
1
2009
177
0.020
 Why?
Neoplastic Stem Cells
1
2009
103
0.020
 Why?
Promoter Regions, Genetic
1
2010
477
0.020
 Why?
Membrane Proteins
1
2010
342
0.020
 Why?
Neoplasm Staging
1
2011
746
0.020
 Why?
Microscopy, Confocal
1
2008
87
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
412
0.020
 Why?
Cell Differentiation
1
2011
653
0.020
 Why?
Chromosome Aberrations
1
2009
298
0.020
 Why?
Survival Rate
1
2010
905
0.020
 Why?
Registries
1
2010
518
0.020
 Why?
Chromosomes, Human
1
2005
41
0.020
 Why?
Time Factors
1
2010
2912
0.010
 Why?
Reproducibility of Results
1
2005
1188
0.010
 Why?
Mice
1
2010
5720
0.010
 Why?
Animals
1
2010
13150
0.010
 Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (236) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (26) people
_
Same Department Expand Description
Search Department